{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:47:08Z","timestamp":1780109228809,"version":"3.54.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pendersfonds, Dutch Pulmonary Fibrosis Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The presence of familial interstitial lung disease (ILD) has been found to predict development of progressive pulmonary fibrosis. However, the role of non-ILD lung diseases in ILD patients\u2019 families has not yet been investigated. We aimed to identify associations between ILDs and non-ILD lung diseases from ILD patients\u2019 self-reported family health history.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analysed questionnaires on family health history of 1164 ILD patients for the occurrence of ILD and non-ILD lung disease in relatives. Logistic regression analysis was used to study associations with diagnosis groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Familial pulmonary fibrosis was reported by 20% of patients with idiopathic pulmonary fibrosis (IPF; OR 9.2, 95% CI 4.7\u201317.9), and 15% of patients with unclassifiable pulmonary fibrosis (OR 4.1, 95% CI 2.0\u20138.2). Familial occurrence was reported by 14% of patients with sarcoidosis (OR 3.3, 95% CI 1.9\u20135.8). Regarding non-ILD lung disease, significantly more patients with IPF (36%) reported lung cancer in their family (OR 2.3, 95% CI 1.4\u20133.5), and patients with hypersensitivity pneumonitis (18%) mostly reported COPD (OR 2.3, 95% CI 1.3\u20134.2). Comparison of sporadic and familial ILD patients\u2019 reports showed that emphysema (OR 4.6, 95% CI 1.8\u201311.6), and lung cancer (OR 2.4, 95% CI 1.2\u20134.9) were predictive for familial pulmonary fibrosis, particularly when reported both in a family (OR 16.7, 95% CI 3.2\u201386.6; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings provide evidence for clustering of ILD and non-ILD lung diseases in families and show that self-reported emphysema and lung cancer of relatives in this population predicts familial pulmonary fibrosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-01927-x","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T17:02:59Z","timestamp":1649350979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clustering of lung diseases in the family of interstitial lung disease patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Michelle","family":"Terwiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coline H. M.","family":"van Moorsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"1927_CR1","doi-asserted-by":"crossref","unstructured":"Borie R, Le Guen P, Ghanem M, Taill\u00e9 C, Dupin C, Dieud\u00e9 P, et al. The genetics of interstitial lung diseases. Vol. 28, European Respiratory Review. European Respiratory Society; 2019.","DOI":"10.1183\/16000617.0053-2019"},{"key":"1927_CR2","doi-asserted-by":"crossref","unstructured":"Borie R, Kannengiesser C, Sicre de Fontbrune F, Gouya L, Nathan N, Crestani B. Management of suspected monogenic lung fibrosis in a specialised centre. Eur Respir Rev. 2017;26(144).","DOI":"10.1183\/16000617.0122-2016"},{"issue":"159","key":"1927_CR3","doi-asserted-by":"publisher","first-page":"200085","DOI":"10.1183\/16000617.0085-2020","volume":"30","author":"CHM van Moorsel","year":"2021","unstructured":"van Moorsel CHM, van der Vis JJ, Grutters JC. Genetic disorders of the surfactant system: focus on adult disease. Eur Respir Rev. 2021;30(159):200085.","journal-title":"Eur Respir Rev"},{"issue":"11","key":"1927_CR4","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","volume":"164","author":"BA Rybicki","year":"2001","unstructured":"Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, et al. Familial aggregation of sarcoidosis. Am J Respir Crit Care Med. 2001;164(11):2085\u201391.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1927_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/thorax.57.4.338","volume":"57","author":"U Hodgson","year":"2002","unstructured":"Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002;57(4):338\u201342.","journal-title":"Thorax"},{"issue":"12","key":"1927_CR6","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.rmed.2011.08.022","volume":"105","author":"C Garc\u00eda-Sancho","year":"2011","unstructured":"Garc\u00eda-Sancho C, Buend\u00eda-Rold\u00e1n I, Fern\u00e1ndez-Plata MR, Navarro C, P\u00e9rez-Padilla R, Vargas MH, et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir Med. 2011;105(12):1902\u20137.","journal-title":"Respir Med"},{"key":"1927_CR7","doi-asserted-by":"crossref","unstructured":"Frisell T, Saevarsdottir S, Askling J. Family history of rheumatoid arthritis: An old concept with new developments. Vol. 12, Nature Reviews Rheumatology. Nature Publishing Group; 2016. p. 335\u201343.","DOI":"10.1038\/nrrheum.2016.52"},{"issue":"10198","key":"1927_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0140-6736(19)31275-9","volume":"394","author":"GS Ginsburg","year":"2019","unstructured":"Ginsburg GS, Wu RR, Orlando LA. Family health history: underused for actionable risk assessment. Lancet (London, England). 2019;394(10198):596\u2013603.","journal-title":"Lancet (London, England)"},{"issue":"3\u20134","key":"1927_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","volume":"33","author":"GS Cooper","year":"2009","unstructured":"Cooper GS, Bynum MLK, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3\u20134):197\u2013207.","journal-title":"J Autoimmun"},{"key":"1927_CR10","doi-asserted-by":"crossref","unstructured":"C\u00e1rdenas-Rold\u00e1n J, Rojas-Villarraga A, Anaya J-M. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med. 2013;11(73).","DOI":"10.1186\/1741-7015-11-73"},{"issue":"5","key":"1927_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/MCP.0000000000000598","volume":"25","author":"M Terwiel","year":"2019","unstructured":"Terwiel M, Grutters JC, van Moorsel CHM. Clustering of immune-mediated diseases in sarcoidosis. Curr Opin Pulm Med. 2019;25(5):539\u201353.","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl 2","key":"1927_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1038\/sj.bjc.6602061","volume":"91 Suppl 2","author":"G Raghu","year":"2004","unstructured":"Raghu G, Nyberg F, Morgan G. The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer. 2004;91 Suppl 2(Suppl 2):S3-10.","journal-title":"Br J Cancer"},{"key":"1927_CR13","doi-asserted-by":"crossref","unstructured":"Hoffman TW, Van Moorsel CHM, Borie R, Crestani B. Pulmonary phenotypes associated with genetic variation in telomere-related genes. Vol. 24, Current Opinion in Pulmonary Medicine. Lippincott Williams and Wilkins; 2018. p. 269\u201380.","DOI":"10.1097\/MCP.0000000000000475"},{"issue":"1","key":"1927_CR14","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1038\/s41598-021-82182-8","volume":"11","author":"MJ Song","year":"2021","unstructured":"Song MJ, Kim SY, Park MS, Kang MJ, Lee SH, Park SC. A nationwide population-based study of incidence and mortality of lung cancer in idiopathic pulmonary fibrosis. Sci Rep. 2021;11(1):2596.","journal-title":"Sci Rep"},{"issue":"1","key":"1927_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12890-019-0895-6","volume":"19","author":"E Krauss","year":"2019","unstructured":"Krauss E, Gehrken G, Drakopanagiotakis F, Tello S, Dartsch RC, Maurer O, et al. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF). BMC Pulm Med. 2019;19(1):130.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"1927_CR16","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.chest.2021.01.026","volume":"159","author":"C Cutting","year":"2021","unstructured":"Cutting C, Bowman WS, Dao N, Pugashetti JV, Garcia CK, Oldham JM, et al. Family history of pulmonary fibrosis predicts worse survival in patients with interstitial lung disease. Chest. 2021;159(5):1913\u201321.","journal-title":"Chest"},{"key":"1927_CR17","doi-asserted-by":"crossref","unstructured":"Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, Slifer SH, et al. Clinical and pathologic features of familial interstitial pneumonia. Vol. 172, American Journal of Respiratory and Critical Care Medicine. 2005. p. 1146\u201352.","DOI":"10.1164\/rccm.200408-1104OC"},{"issue":"7","key":"1927_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1164\/rccm.200702-254OC","volume":"176","author":"IO Rosas","year":"2007","unstructured":"Rosas IO, Ren P, Avila NA, Chow CK, Franks TJ, Travis WD, et al. Early interstitial lung disease in familial pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176(7):698\u2013705.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1927_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1378\/chest.11-2812","volume":"142","author":"HY Lee","year":"2012","unstructured":"Lee HY, Seo JB, Steele MP, Schwarz MI, Brown KK, Loyd JE, et al. High-resolution CT scan findings in familial interstitial pneumonia do not conform to those of idiopathic interstitial pneumonia. Chest. 2012;142(6):1577\u201383.","journal-title":"Chest"},{"issue":"4","key":"1927_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.201406-1162OC","volume":"191","author":"JA Kropski","year":"2015","unstructured":"Kropski JA, Pritchett JM, Zoz DF, Crossno PF, Markin C, Garnett ET, et al. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. Am J Respir Crit Care Med. 2015;191(4):417\u201326.","journal-title":"Am J Respir Crit Care Med"},{"key":"1927_CR21","doi-asserted-by":"crossref","unstructured":"Hunninghake GM, Quesada-Arias LD, Carmichael NE, Martinez Manzano JM, Poli De Fr\u00edas S, Baumgartner MA, et al. Interstitial lung disease in relatives of patients with pulmonary fibrosis. Am J Respir Crit Care Med. 2020;201(10).","DOI":"10.1164\/rccm.201908-1571OC"},{"issue":"8","key":"1927_CR22","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official american thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26-51.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1927_CR23","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","volume":"202","author":"G Raghu","year":"2020","unstructured":"Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202(3):e36-69.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1927_CR24","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44-68.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1927_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1927_CR26","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, Du Bois RM, et al. An official European Respiratory Society\/ American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976\u201387.","journal-title":"Eur Respir J"},{"key":"1927_CR27","doi-asserted-by":"crossref","unstructured":"Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V. Interstitial lung disease. Vol. 23, European Respiratory Review. European Respiratory Society; 2014. p. 40\u201354.","DOI":"10.1183\/09059180.00009113"},{"issue":"150","key":"1927_CR28","doi-asserted-by":"publisher","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","volume":"27","author":"V Cottin","year":"2018","unstructured":"Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180076.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"1927_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"1927_CR30","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"11","key":"1927_CR31","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.5858\/arpa.2011-0627-OAI","volume":"136","author":"KO Leslie","year":"2012","unstructured":"Leslie KO, Cool CD, Sporn TA, Curran-Everett D, Steele MP, Brown KK, et al. Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients. Arch Pathol Lab Med. 2012;136(11):1366\u201376.","journal-title":"Arch Pathol Lab Med"},{"key":"1927_CR32","doi-asserted-by":"crossref","unstructured":"CH van M, MF van O, NP B, PA de J, JJ van der V, HJ R, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. Am J Respir Crit Care Med. 2010;182(11).","DOI":"10.1164\/rccm.200906-0953OC"},{"key":"1927_CR33","doi-asserted-by":"crossref","unstructured":"Salisbury ML, Hewlett JC, Ding G, Markin CR, Douglas K, Mason W, et al. Development and progression of radiologic abnormalities in individuals at risk for familial interstitial lung disease. Am J Respir Crit Care Med. 2020;201(10).","DOI":"10.1164\/rccm.201909-1834OC"},{"issue":"2","key":"1927_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.chest.2020.03.069","volume":"158","author":"JJ van der Vis","year":"2020","unstructured":"van der Vis JJ, van der Smagt JJ, Hennekam FAM, Grutters JC, van Moorsel CHM. Pulmonary fibrosis and a TERT founder mutation with a latency period of 300 years. Chest. 2020;158(2):612\u20139.","journal-title":"Chest"},{"issue":"3","key":"1927_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/MCP.0000000000000476","volume":"24","author":"CHM van Moorsel","year":"2018","unstructured":"van Moorsel CHM. Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2018;24(3):309\u201317.","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"1927_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1164\/rccm.202002-0460OC","volume":"203","author":"R Invernizzi","year":"2021","unstructured":"Invernizzi R, Wu BG, Barnett J, Ghai P, Kingston S, Hewitt RJ, et al. The respiratory microbiome in chronic hypersensitivity pneumonitis is distinct from that of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2021;203(3):339\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1927_CR37","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1378\/chest.127.6.2034","volume":"127","author":"H-L Lee","year":"2005","unstructured":"Lee H-L, Ryu JH, Wittmer MH, Hartman TE, Lymp JF, Tazelaar HD, et al. Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest. 2005;127(6):2034\u201341.","journal-title":"Chest"},{"issue":"6","key":"1927_CR38","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","volume":"48","author":"CA Newton","year":"2016","unstructured":"Newton CA, Batra K, Torrealba J, Kozlitina J, Glazer CS, Aravena C, et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J. 2016;48(6):1710\u201320.","journal-title":"Eur Respir J"},{"key":"1927_CR39","doi-asserted-by":"crossref","unstructured":"Diaz de Leon A, Cronkhite JT, Katzenstein ALA, Godwin JD, Raghu G, Glazer CS, et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) Mutations. PLoS ONE. 2010;5(5).","DOI":"10.1371\/journal.pone.0010680"},{"issue":"4","key":"1927_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/resp.12728","volume":"21","author":"JJ Van Der Vis","year":"2016","unstructured":"Van Der Vis JJ, Snetselaar R, Kazemier KM, Ten Klooster L, Grutters JC, Van Moorsel CHM. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias. Respirology. 2016;21(4):712\u20137.","journal-title":"Respirology"},{"issue":"2","key":"1927_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/rccm.201810-1891OC","volume":"200","author":"C Moore","year":"2019","unstructured":"Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, et al. Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(2):199\u2013208.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"1927_CR42","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","volume":"5","author":"TM Maher","year":"2017","unstructured":"Maher TM, Oballa E, Simpson JK, Porte J, Habgood A, Fahy WA, et al. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017;5(12):946\u201355.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"1927_CR43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2217\/bmm-2020-0165","volume":"14","author":"SA Moll","year":"2020","unstructured":"Moll SA, Wiertz IA, Vorselaars ADM, Zanen P, Ruven HJT, Van Moorsel CHM, et al. Serum biomarker CA 15\u20133 as predictor of response to antifibrotic treatment and survival in idiopathic pulmonary fibrosis. Biomark Med. 2020;14(11):997\u20131007.","journal-title":"Biomark Med"},{"key":"1927_CR44","doi-asserted-by":"crossref","unstructured":"Adegunsoye A, Oldham JM, Bellam SK, Chung JH, Chung PA, Biblowitz KM, et al. African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018;51(6).","DOI":"10.1183\/13993003.00255-2018"},{"issue":"4","key":"1927_CR45","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.rmed.2012.01.002","volume":"106","author":"JJ Swigris","year":"2013","unstructured":"Swigris JJ, Olson AL, Huie TJ, Fernandez- ER, Solomon J, Sprunger D, et al. Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death. Respir Med. 2013;106(4):588\u201393.","journal-title":"Respir Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01927-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-01927-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01927-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T17:03:34Z","timestamp":1649351014000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-01927-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1927"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-01927-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical research Ethics Committees United (MEC-U) of the St Antonius Hospital (R05-08A) and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The research was conducted in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"In accordance statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}